This page contains research and articles pertaining to cannabis-related adverse events. Common adverse events, or side effects, can be cannabinoid-specific, such as being related to THC (e.g., dizziness, cognitive effects, anxiety, dry mouth). Adverse events can also be specific to the route of administration (e.g., cough, phlegm, or bronchitis from smoking cannabis).
Original Article
Cannabidiol-Associated Hepatotoxicity: A Systematic Review and Meta-Analysis
Journal of Internal Medicine. 2023
Lo LA,… MacCallum CA
Brief Report
Factors Associated with Problematic Cannabis Use in a Sample of Medical Cannabis Dispensary Users
Psychiatry and Clinical Psychopharmacology. 2022
Lo LA, MacCallum CA, Yau J, Panenka W, Barr A.
Chapter 36
Cannabinoid-Related Adverse Events and Impairment
Narouze SN, MacCallum CA. eds. Cannabinoids and Pain. Springer; 2021
A randomised controlled trial of vaporised Δ 9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects. European Archives of Psychiatry and Clinical Neuroscience. 2019
Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophrenia Bulletin. 2013; 40(6)
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Current Pharmaceutical Design. 2012; 18(32)